Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M Foss

Showing results (21-30 of 258) with videos related to

Pageof 26
Sort By:
Oncology (Williston Park, N.Y.)|January 2, 2010
The importance of accurately characterizing lymphoproliferative diseaseFrancine M Foss
Oncology (Williston Park, N.Y.)|July 11, 2000
Combination therapy with purine nucleoside analogsF M Foss
Cancer Journal (Sudbury, Mass.)|March 24, 2011
Molecular predictors of response in aggressive T-cell lymphomasFrancine M Foss
Genetics|November 1, 1993
Molecular definition of the PAS1-1 mutation which affects silencing in Saccharomyces cerevisiaeM Foss, J Rine
Health Trends|December 10, 1990
Day care surgery for the correction of hallux valgusS Tibrewal, M Foss
Drugs|February 20, 2010
Current and emerging treatment strategies for cutaneous T-cell lymphomaFrederick Lansigan, Francine M Foss
Expert Opinion on Biological Therapy|June 9, 2025
An evaluation of denileukin diftitox for the treatment of relapsed or refractory cutaneous T-cell lymphomaAmrita Goyal, Francine M Foss
Frontiers in Public Health|December 16, 2020
Catastrophic Health Impacts of Spiraling Climate Change: How Certain Can We Be About Their Magnitudes?Zaid Chalabi, Anna M Foss
Hematology/Oncology Clinics of North America|March 26, 2017
Mycosis Fungoides and Sezary SyndromeFrancine M Foss, Michael Girardi
Seminars in Oncology|December 19, 2007
Mycosis fungoides: pathophysiology and emerging therapiesMadeleine Duvic, Francine M Foss
Pageof 26

Showing results (21-30 of 258) with videos related to

Sort By:
Pageof 26
Oncology (Williston Park, N.Y.)|January 2, 2010
The importance of accurately characterizing lymphoproliferative diseaseFrancine M Foss
Oncology (Williston Park, N.Y.)|July 11, 2000
Combination therapy with purine nucleoside analogsF M Foss
Cancer Journal (Sudbury, Mass.)|March 24, 2011
Molecular predictors of response in aggressive T-cell lymphomasFrancine M Foss
Genetics|November 1, 1993
Molecular definition of the PAS1-1 mutation which affects silencing in Saccharomyces cerevisiaeM Foss, J Rine
Health Trends|December 10, 1990
Day care surgery for the correction of hallux valgusS Tibrewal, M Foss
Drugs|February 20, 2010
Current and emerging treatment strategies for cutaneous T-cell lymphomaFrederick Lansigan, Francine M Foss
Expert Opinion on Biological Therapy|June 9, 2025
An evaluation of denileukin diftitox for the treatment of relapsed or refractory cutaneous T-cell lymphomaAmrita Goyal, Francine M Foss
Frontiers in Public Health|December 16, 2020
Catastrophic Health Impacts of Spiraling Climate Change: How Certain Can We Be About Their Magnitudes?Zaid Chalabi, Anna M Foss
Hematology/Oncology Clinics of North America|March 26, 2017
Mycosis Fungoides and Sezary SyndromeFrancine M Foss, Michael Girardi
Seminars in Oncology|December 19, 2007
Mycosis fungoides: pathophysiology and emerging therapiesMadeleine Duvic, Francine M Foss
Pageof 26